Position in ABBV
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$5,518,465
+$903,763 QoQ
Shares Held
21,930
+3.4% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
2.26%
of 13F equity value
Holder Rank
#1,253
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Shoker Investment Counsel, Inc. holds $20,628,640 across 8 Drug Manufacturers - General names. ABBV ranks #1 (26.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
21,930 | $5,518,465 | |
| 2 | JNJ |
Johnson & Johnson
|
18,845 | $4,786,064 | |
| 3 | MRK |
Merck & Co., Inc.
|
29,948 | $3,848,318 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
20,774 | $2,624,587 | |
| 5 | PFE |
Pfizer Inc
|
99,923 | $2,406,145 | |
| 6 | LLY |
ELI LILLY & Co
|
668 | $801,219 | |
| 7 | NVS |
Novartis AG
|
2,335 | $365,941 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,823 | $277,901 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,518,465 | 21,930 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $4,614,702 | 21,218 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $5,020,382 | 21,972 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $5,241,834 | 22,639 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $4,218,956 | 22,729 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $4,861,702 | 23,204 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $4,102,382 | 23,086 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $4,619,452 | 23,392 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $4,123,169 | 24,039 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $4,537,567 | 24,918 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $3,839,536 | 24,776 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $3,676,713 | 24,666 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $3,337,262 | 24,770 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $3,948,710 | 24,777 | Shares | Sole | 2023-05-03 | |
| 2022-12-31 | $4,007,604 | 24,798 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $3,444,902 | 25,668 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $3,854,118 | 25,164 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $4,100,896 | 25,297 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $3,438,212 | 25,393 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $2,804,943 | 26,003 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $2,883,921 | 25,603 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $2,732,446 | 25,249 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $3,000,842 | 28,006 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $2,436,053 | 27,812 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $2,721,353 | 27,718 | Shares | Sole | 2020-08-07 | |
| 2020-03-31 | $2,092,405 | 27,463 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||